Three allele combinations associated with multiple sclerosis

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Favorova, Olga O ^a,b   Favorov, Alexander V ^c   Boiko, Alexey N ^a   Andreewski, Timofey V ^b   Sudomoina, Marina A ^a,b   Alekseenkov, Alexey D ^b   Kulakova, Olga G ^a   Gusev, Eugenyi I ^a   Parmigiani, Giovanni ^d   Ochs, Michael F ^e  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^c GosNIIGenetika   (Russian Federation)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; HLA DR ANTIGEN; LYMPHOTOXIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE INTERACTION; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; MONTE CARLO METHOD; MULTIGENE FAMILY; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; POLYMERASE CHAIN REACTION; PROBABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION STUDY;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HLA-DRB1 CHAINS; HUMANS; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RUSSIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748186680     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-63     Document Type: Article

References (44)

1. Hirschhorn JN, Daly MJ: Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005, 6(2):95-108.
2. Thornton-Wells TA, Moore JH, Haines JL: Genetics, statistics and human disease: analytical retooling for complexity. Trends Genet 2004, 20(12):640-647.
3. Threadgill DW, Hunter KW, Williams RW: Genetic dissection of complex and quantitative traits: from fantasy to reality via a community effort. Mamm Genome 2002, 13(4):175-178.
4. Bomprezzi R, Kovanen PE, Martin R: New approaches to investigating heterogeneity in complex traits. J Med Genet 2003, 40(8):553-559.
5. Herrera BM, Ebers GC: Progress in deciphering the genetics of multiple sclerosis. Curr Opin Neurol 2003, 16(3):253-258.
6. Kalman B, Albert RH, Leist TP: Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration. Autoimmunity 2002, 35(4):225-234.
7. Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, et al.: A second-generation genomic screen for multiple sclerosis. Am J Hum Genet 2004, 75(6):1070-1078.
8. Sawcer S, Ban M, Maranian M, Yeo, TW, Compston A, Kirby A, Daly MJ, De Jager PL, Walsh E, Lander ES, et al.: A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005, 77(3):454-467.
9. GAMES, Transatlantic Multiple Sclerosis Genetics Cooperative: A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol 2003, 143(1-2):39-46.
10. Kenealy SJ, Pericak-Vance MA, Haines JL: The genetic epidemiology of multiple sclerosis. J Neuroimmunol 2003, 143(1-2):7-12.
11. Risch NJ: Searching for genetic determinants in the new millennium. Nature 2000, 405(6788):847-856.
12. Dyment DA, Ebers GC, Sadovnick AD: Genetics of multiple sclerosis. Lancet Neurol 2004, 3(2):104-110.
13. Alizadeh M, Babron MC, Birebent B, Matsuda F, Quelvennec E, Liblau R, Cournu-Rebeix I, Momigliano-Richiardi P, Sequeiros J, Yaouanq J, et al.: Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients. Ann Neurol 2003, 54(1):119-122.
14. Dyment DA, Steckley JL, Morrison K, Willer CJ, Cader MZ, DeLuca GC, Sadovnick AD, Risch N, Ebers GC: TCR beta polymorphisms and multiple sclerosis. Genes Immun 2004, 5(5):337-342.
15. Favorova OO, Andreewski TV, Boiko AN, Sudomoina MA, Alekseenkov AD, Kulakova OG, Slanova AV, Gusev EI: The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians. Neurology 2002, 59(10):1652-1655.
16. Green AJ, Barcellos LF, Rimmler JB, Garcia ME, Caillier S, Lincoln RR, Bucher P, Pericak-Vance MA, Haines JL, Hauser SL, et al.: Sequence variation in the transforming growth factor-beta 1 (TGFB1) gene and multiple sclerosis susceptibility. J Neuroimmunol 2001, 116(1):116-124.
17. Guerini FR, Ferrante P, Losciale L, Caputo D, Lombardi ML, Pirozzi G, Luongo V, Sudomoina MA, Andreewski TV, Alekseenkov AD, et al.: Myelin basic protein gene is associated with MS in DR4-and DR5-positive Italians and Russians. Neurology 2003, 61(4):520-526.
18. Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA: Analysis of IL4R haplotypes in predisposition to multiple sclerosis. Genes Immun 2004, 5(2):138-141.
19. Nejentsev S, Laaksonen M, Tienari PJ, Fernandez O, Cordell H, Ruutiainen J, Wikstrom J, Pastinen T, Kuokkanen S, Hillert J, et al.: Intercellular adhesion molecule-1 K469E polymorphism: study of association with multiple sclerosis. Hum Immunol 2003, 64(3):345-349.
20. Favorov AV, Andreewski TV, Sudomoina MA, Favorova OO, Parmigiani G, Ochs MF: A Markov Chain Monte Carlo Technique for Identification of Combinations of Allelic Variants Underlying Complex Diseases. Genetics 2005, 171(4):2113-2121.
21. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, et al.: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50(1):121-127.
22. Sudomoina MA, Boiko AN, Demina TL, Gusev EI, Boldyreva MN, Trofimov D, Alekseev LP, Favorova OO: Connection of multiple sclerosis in the Russian population with alleles of the major histocompatibility complex DRB1 gene. Mol Biol (Mosk) 1998, 32(2):291-296.
23. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL: DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. J Immunol 1991, 147(3):1053-1059.
24. Gallagher G, Eskdale J, Oh HH, Richards SD, Campbell DA, Field M: Polymorphisms in the TNF gene cluster and MHC serotypes in the West of Scotland. Immunogenetics 1997, 45(3):188-194.
25. He B, Navikas V, Lundahl J, Soderstrom M, Hillert J: Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J Neuroimmunol 1995, 63(2):143-147.
26. GeneFisher [http://bibiserv.techfak.uni-bielefeld.de/genefisher]
27. Roth MP, Nogueira L, Coppin H, Clanet M, Clayton J, Cambon-Thomsen A: Tumor necrosis factor polymorphism in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 1994, 51(1):93-99.
28. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O: Polymorphisms of the transforming growth factor-beta I gene in relation to myocardial infarction and blood pressure. The Etude CasTemoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996, 28(5):881-887.
29. Bignon JD, Fernandez-Vina MF: Technical Handbook: Twelfth International Histocombatibility Workshop and Conference. Paris: HLA et Me'decine; 1996.
30. Sandford AJ, Pare PD: Direct PCR of small genomic DNA fragments from serum. Biotechniques 1997, 23(5):890-892.
31. Marron MP, Raffel LJ, Garchon HJ, Jacob CO, Serrano-Rios M, Martinez Larrad MT, Teng WP, Park Y, Zhang ZX, Goldstein DR, et al.: Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997, 6(8):1275-1282.
32. Robert C, Casella G: Monte Carlo Statistical Methods. New York. Springer Verlag; 1999.
33. Metropolis N, Rosenbluth A, Rosenbluth M, Teller A, Teller E: Equations of state calculations by fast computing machines. J Chem Phys 1953, 21:1087-1091.
34. Schneider S, Roessli D, Excoffier L: Arlequin: A software for population genetics data analysis. Ver 2.000. 2000 [http://cmpg.unibe.ch/software/ arlequin3/]. Genetics and Biometry Lab, Dept. of Anthropology, University of Geneva; Arlequin
35. Efron B, Tibshirani R, Storey JD, Tusher V: Empirical Bayes Analysis of a Microarray Experiment. J Am Statist Assoc 2001, 96(456):1151-1160.
36. Boiko AN, Gusev EI, Sudomoina MA, Alekseenkov AD, Kulakova OG, Bikova OV, Maslova OI, Guseva MR, Boiko SY, Guseva ME, et al.: Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology 2002, 58(4):658-660.
37. Gusev E, Sudomoina M, Boiko A, Deomina T, Favorova O: TNF gene polymorphisms: associations with multiple sclerosis susceptibility and severity. In Frontiers in multiple sclerosis Edited by: O A, H O. London: Martin Dunitz; 1997:35-41.
38. de Jong BA, Huizinga TW, Zanelli E, Giphart MJ, Bollen EL, Uitdehaag BM, Polman CH, Westendorp RG: Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region. Neurology 2002, 59(4):549-555.
39. Alegre ML, Frauwirth KA, Thompson CB: T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001, 1(3):220-228.
40. Maurer M, Loserth S, Kolb-Maurer A, Ponath A, Wiese S, Kruse N, Rieckmann P: A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation. Immunogenetics 2002, 54(1):1-8.
41. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD: Genetic control of the circulating concentration of transforming growth factor type beta 1. Hum Mol Genet 1999, 8(1):93-97.
42. Uboldi de Capei MU, Dametto E, Fasano ME, Rendine S, Curtoni ES: Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenet 2003, 30(1):5-10.
43. Grove J, Daly AK, Bassendine MF, Day CP: Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997, 26(1):143-146.
44. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, et al.: Nomenclature for factors of the HLA system, 2002. Hum Immunol 2002, 63(12):1213-1268.